About Senseonics (NYSEAMERICAN:SENS)
Senseonics Holdings, Inc., a medical technology company, designs, develops, and commercializes glucose monitoring systems for people with diabetes primarily in Europe. Its product includes Eversense, a first generation continuous glucose monitoring system, which measures glucose levels in people with diabetes for a period of up to 90 days. The company has a research and development license agreement with TypeZero Technologies, Inc. to develop artificial pancreas and decision support systems that use the Eversense continuous glucose monitoring system. It also has collaboration agreement with Roche Diabetes Care, Inc. to develop an automated insulin delivery system. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNYSEAMERICAN:SENS
CUSIPN/A
Phone+1-301-5157260
Debt
Debt-to-Equity Ratio0.76%
Current Ratio2.93%
Quick Ratio2.81%
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$330,000.00
Price / Sales1,372.40
Cash FlowN/A
Price / CashN/A
Book Value($0.05) per share
Price / Book-66.00
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-43,930,000.00
Net Margins-828.76%
Return on Equity-406.72%
Return on Assets-129.94%
Miscellaneous
Employees58
Outstanding Shares137,240,000
Senseonics (NYSEAMERICAN:SENS) Frequently Asked Questions
What is Senseonics' stock symbol?
Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS."
How were Senseonics' earnings last quarter?
Senseonics Holdings (NYSEAMERICAN:SENS) issued its earnings results on Tuesday, March, 13th. The company reported ($0.12) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.13) by $0.01. The firm earned $2.90 million during the quarter, compared to analysts' expectations of $2.95 million. Senseonics had a negative net margin of 828.76% and a negative return on equity of 406.72%. The firm's revenue was up 866.7% compared to the same quarter last year. View Senseonics' Earnings History.
What price target have analysts set for SENS?
4 Wall Street analysts have issued 12 month target prices for Senseonics' shares. Their predictions range from $4.00 to $6.00. On average, they anticipate Senseonics' stock price to reach $4.8333 in the next twelve months. View Analyst Ratings for Senseonics.
What are Wall Street analysts saying about Senseonics stock?
Here are some recent quotes from research analysts about Senseonics stock:
- 1. Canaccord Genuity analysts commented, "We maintain our BUY rating on SENS following the FDA’s scheduling of an advisory committee (adcom panel) meeting to review Senseonics’ Eversense. The meeting is scheduled for Thursday, March 29, and comes just in time to meet management’s guidance for a Q1/18 event. As a reminder, management has guided to a US regulatory approval and commercial launch ~2 months after the adcom panel, positioning the company for a late Q2/18 launch – but we model for first US revenues in the Q3/18. We expect trading activity to increase in coming weeks in anticipation of the event, which we believe will be positive given the strong safety and efficacy data from its pivotal trial. Investment highlights The FDA announced that the Clinical Chemistry and Clinical Toxicology Devices Panel will review and make recommendations on Senseonics’ Eversense PMA submission. The adcom panel is scheduled for Thursday, March 29, 2018 and will be held in Washington DC." (3/2/2018)
- 2. According to Zacks Investment Research, "Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States. " (8/15/2017)
- 3. BTIG Research analysts commented, "Significant Positive SENS this morning announced that they raised $41M (29M shares @ $1.41), which in our opinion has been a key focus for potential investors for some time. We see it as a positive that they were able to raise at the current share price without warrants and that Roche (RHHBY, Not Rated), one of their key distributors, decided to participate. We expect shares to trade up post this raise and into the FDA approval anticipated later this year." (5/28/2017)
Are investors shorting Senseonics?
Senseonics saw a increase in short interest during the month of March. As of March 29th, there was short interest totalling 6,366,980 shares, an increase of 9.4% from the March 15th total of 5,819,616 shares. Based on an average trading volume of 829,313 shares, the days-to-cover ratio is currently 7.7 days. Approximately 12.5% of the shares of the stock are sold short.
Who are some of Senseonics' key competitors?
Some companies that are related to Senseonics include Sandstorm Gold (SAND), MAG Silver (MAG), Par Pacific (PARR), Ring Energy (REI), Nevsun Resources (NSU), Ladenburg Thalmann (LTS), Silvercorp Metals (SVM), Envirostar (EVI), Gold Standard Ventures (GSV), Consolidated-Tomoka Land (CTO), Sierra Metals (SMTS), Golden Star Resources (GSS), SafeStitch Medical (TRXC), Polymet Mining (PLM), Taseko Mines (TGB), BioTime (BTX), 22nd Century Group (XXII) and Protalix Biotherapeutics (PLX).
Who are Senseonics' key executives?
Senseonics' management team includes the folowing people:
- Dr. Timothy T. Goodnow Ph.D., Chief Exec. Officer, Pres and Director (Age 56)
- Mr. R. Don Elsey MBA, Chief Financial Officer, Sec. and Treasurer (Age 64)
- Dr. E. Lynne Kelley M.D., FACS, Chief Medical Officer (Age 55)
- Dr. Mukul Jain Ph.D., Chief Operating Officer (Age 45)
- Ms. Mirasol G. Panlilio, VP & Gen. Mang. of Global Commercial Operations (Age 53)
Has Senseonics been receiving favorable news coverage?
News stories about SENS stock have trended somewhat positive on Monday, according to Accern Sentiment. The research firm ranks the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Senseonics earned a media sentiment score of 0.14 on Accern's scale. They also gave media stories about the company an impact score of 47.59 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
How do I buy shares of Senseonics?
Shares of SENS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Senseonics' stock price today?
One share of SENS stock can currently be purchased for approximately $3.30.
How big of a company is Senseonics?
Senseonics has a market capitalization of $434.88 million and generates $330,000.00 in revenue each year. Senseonics employs 58 workers across the globe.
How can I contact Senseonics?
Senseonics' mailing address is 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States. The company can be reached via phone at +1-301-5157260.
MarketBeat Community Rating for Senseonics (SENS)
MarketBeat's community ratings are surveys of what our community members think about Senseonics and other stocks. Vote "Outperform" if you believe SENS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SENS will underperform the S&P 500 over the long term. You may vote once every thirty days.
Senseonics (NYSEAMERICAN:SENS) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
4 Wall Street analysts have issued ratings and price targets for Senseonics in the last 12 months. Their average twelve-month price target is $4.8333, suggesting that the stock has a possible upside of 46.46%. The high price target for SENS is $6.00 and the low price target for SENS is $4.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 3.00 | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $4.8333 | $4.25 | $4.50 | $4.50 |
| Price Target Upside: | 46.46% upside | 33.65% upside | 54.11% upside | 51.52% upside |
Senseonics (NYSEAMERICAN:SENS) Consensus Price Target History
Senseonics (NYSEAMERICAN:SENS) Analyst Ratings History
Show:
(Data available from 4/23/2016 forward)
Senseonics (NYSEAMERICAN:SENS) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Senseonics (NYSEAMERICAN SENS) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 34.10%
Institutional Ownership Percentage: 30.66%
Senseonics (NYSEAMERICAN SENS) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 4/9/2018 | Mukul Jain | COO | Sell | 15,706 | $3.85 | $60,468.10 | |  |
| 4/6/2018 | Mukul Jain | COO | Sell | 24,294 | $3.75 | $91,102.50 | | |
| 4/2/2018 | Mukul Jain | COO | Sell | 27,437 | $3.25 | $89,170.25 | | |
| 12/8/2017 | Peter J Barris | Major Shareholder | Sell | 139,645 | $2.63 | $367,266.35 | | |
| 10/2/2017 | Mukul Jain | COO | Sell | 11,885 | $3.25 | $38,626.25 | | |
| 9/11/2017 | Mukul Jain | COO | Sell | 13,115 | $3.25 | $42,623.75 | 13,115 | |
| 6/1/2017 | Enterprise Associates 10 L New | Major Shareholder | Buy | 7,092,198 | $1.41 | $9,999,999.18 | | |
(Data available from 1/1/2013 forward)
Senseonics (NYSEAMERICAN SENS) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | BRIEF-Senseonics Holdings Files For Mixed Shelf Of Up To $200 Mln
www.reuters.com - April 20 at 9:54 AM |
 | Does Senseonics Holdings Inc’s (NYSEMKT:SENS) -34.53% Earnings Drop Reflect A Longer Term Trend?
finance.yahoo.com - April 13 at 10:09 AM |
 | Senseonics (SENS) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - April 12 at 12:03 PM |
| Senseonics Holdings Inc (SENS) COO Sells $60,468.10 in Stock
www.americanbankingnews.com - April 11 at 7:27 PM |
| Senseonics Holdings Inc (SENS) Short Interest Update
www.americanbankingnews.com - April 10 at 6:56 PM |
| Senseonics Holdings Inc (SENS) COO Mukul Jain Sells 24,294 Shares
www.americanbankingnews.com - April 9 at 7:19 PM |
| Senseonics Holdings (SENS) Jumps: Stock Rises 5.7%
finance.yahoo.com - April 9 at 9:57 AM |
| What Stocks Perform Well in the Midst of a Trade War?
finance.yahoo.com - April 8 at 8:40 AM |
| Mukul Jain Sells 27,437 Shares of Senseonics Holdings Inc (SENS) Stock
www.americanbankingnews.com - April 4 at 11:17 PM |
 | Here's Why Senseonics Holdings Inc. Is Rising Today
www.msn.com - April 4 at 5:16 PM |
| Senseonics (SENS) Research Coverage Started at Guggenheim
www.americanbankingnews.com - April 3 at 9:19 PM |
 | Senseonics Hikes on FDA Outcome
www.baystreet.ca - April 2 at 4:19 PM |
 | Senseonics Holdings (SENS) Announces Favorable AdCom Vote for the Eversense System
www.streetinsider.com - March 30 at 9:49 AM |
| BRIEF-Senseonics Announces Favorable Outcome Of FDA Advisory Committee On The Eversense System
www.reuters.com - March 30 at 9:49 AM |
 | FDA Ad Com Thursday for Senseonics Eversense CGM; shares down 5% on data accuracy questions
seekingalpha.com - March 27 at 4:13 PM |
| Senseonics Holdings Inc (SENS) Short Interest Down 1.8% in March
www.americanbankingnews.com - March 27 at 1:27 AM |
| Edited Transcript of SENS earnings conference call or presentation 13-Mar-18 8:30pm GMT
finance.yahoo.com - March 18 at 9:36 AM |
| Leerink Swann Weighs in on Senseonics Holdings Inc's Q1 2018 Earnings (SENS)
www.americanbankingnews.com - March 16 at 7:56 AM |
| Senseonics Holdings Inc Forecasted to Earn Q1 2019 Earnings of ($0.13) Per Share (SENS)
www.americanbankingnews.com - March 15 at 11:42 AM |
| Senseonics (SENS) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS
www.americanbankingnews.com - March 14 at 9:43 AM |
| Short Interest in Senseonics Holdings Inc (SENS) Expands By 5.5%
www.americanbankingnews.com - March 9 at 6:04 PM |
| Senseonics Announces Date for FDA Advisory Panel
finance.yahoo.com - March 9 at 10:20 AM |
| Senseonics (SENS) Earns "Buy" Rating from Canaccord Genuity
www.americanbankingnews.com - March 2 at 9:11 PM |
| Senseonics to Participate in Upcoming Investor Conferences
finance.yahoo.com - February 28 at 4:48 PM |
| Senseonics Holdings Inc (SENS) Sees Significant Increase in Short Interest
www.americanbankingnews.com - February 27 at 5:40 PM |
 | Eversense CGM System, World's Longest Lasting CGM Sensor, Announces Approval and Launch of Remote Monitoring Feature for EMEA Markets
www.finanznachrichten.de - February 21 at 9:53 AM |
| Eversense® CGM System, World's Longest Lasting CGM Sensor, Announces Approval and Launch of Remote Monitoring Feature for EMEA Markets
finance.yahoo.com - February 21 at 9:53 AM |
| Short Interest in Senseonics Holdings Inc (SENS) Grows By 17.5%
www.americanbankingnews.com - February 9 at 8:28 PM |
| Senseonics to Participate in LEERINK Partners 7th Annual Global Healthcare Conference
finance.yahoo.com - February 8 at 9:03 AM |
| BRIEF-Senseonics Announces Pricing Of $50 Mln Convertible Notes Offering
www.reuters.com - January 26 at 4:34 PM |
| Senseonics Holdings (SENS) Plans Convertible Senior Subordinated Notes Offering
www.streetinsider.com - January 26 at 4:34 PM |
 | This Explains Why Senseonics Holdings Inc. Is Falling Today
www.fool.com - January 26 at 1:14 PM |
| Senseonics Announces Pricing of $50 Million Convertible Notes Offering
finance.yahoo.com - January 26 at 9:05 AM |
| Senseonics Announces Proposed Convertible Senior Subordinated Notes Offering
finance.yahoo.com - January 25 at 4:34 PM |
| Senseonics Holdings Inc (SENS) Short Interest Up 2.1% in January
www.americanbankingnews.com - January 24 at 5:40 PM |
 | Pre-Market Technical Scan on Medical Equipment Equities -- Senseonics, Aethlon Medical, CHF Solutions, and Second Sight Medical Products
www.bizjournals.com - January 22 at 5:40 PM |
| Senseonics Holdings Inc (SENS) Sees Large Decrease in Short Interest
www.americanbankingnews.com - January 11 at 1:22 AM |
| Senseonics Holdings, Inc. breached its 50 day moving average in a Bearish Manner : SENS-US : December 22, 2017
finance.yahoo.com - December 22 at 9:02 AM |
| Senseonics Holdings Inc (SENS) Major Shareholder Sells $367,266.35 in Stock
www.americanbankingnews.com - December 8 at 5:50 PM |
| Senseonics Holdings Inc (SENS) Sees Large Increase in Short Interest
www.americanbankingnews.com - November 27 at 8:24 PM |
Senseonics (NYSEAMERICAN:SENS) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Senseonics (NYSEAMERICAN SENS) Stock Chart for Monday, April, 23, 2018
Loading chart…
